Drug Trial Radar · NCT00486200
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
Last checked: Nov 19, 2026Latest source record: Dec 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
695
Actual
Start
Jun 21, 2007
Primary completion
Aug 12, 2008
Study completion Aug 12, 2008
Sponsor
- Lead sponsor
- Astellas Pharma IncAstellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Jun 14, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Conditions
- Herpes Genitalis
Interventions
ASP2151Drug
Oral administration.
valacyclovirDrug
Oral administration of active comparator.
PlaceboDrug
Oral administration of placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare the efficacy and safety of ASP2151 with valacyclovir and placebo in the acute treatment of recurrent genital Herpes Simplex Virus InfectionTime frame: 17 days
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Los Angeles, California
Site not named
Sacramento, California
Site not named
San Diego, California
Site not named
Westlake Village, California
Site not named
Denver, Colorado
Site not named
Boynton Beach, Florida
Site not named
Miami, Florida
Site not named
Atlanta, Georgia
Site not named
Indianapolis, Indiana
Site not named
Madisonville, Kentucky
Site not named
Baltimore, Maryland
Site not named
Billings, Montana
Site not named
Omaha, Nebraska
Site not named
Albuquerque, New Mexico
Site not named
Portland, Oregon
Site not named
Philadelphia, Pennsylvania
Site not named
Arlington, Texas
Site not named
Houston, Texas
Site not named
Houston, Texas
Site not named
Salt Lake City, Utah
Site not named
Annandale, Virginia
Site not named
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.